miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 22, 2026

D-Wave (QBTS) Q4 2024 Earnings Call Transcript

View original at finance.yahoo.com
D-Wave (QBTS) Q4 2024 Earnings Call Transcript Image source: The Motley Fool. Date Thursday, March 13, 2025 at 8 a.m. ET Call participants Chief Executive Officer — Alan Baratz Chief Financial Officer — John Markovich Need a quote from a Motley Fool analyst?…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Quantum is not ready

    80% confidence
  • D-Wave will be first pure play quantum company to reach profitability

    80% confidence
  • D-Wave is the only quantum company that can claim it has outperformed classical on useful problem of relevance to business and science today

    80% confidence
  • D-Wave is the only company that can meet all Quantum Realized criteria right now

    80% confidence
  • 1,200 qubit Advantage 2 is significantly more powerful than 5,000 qubit Advantage

    80% confidence
  • Discounted usefulness of quantum computing

    80% confidence
  • System sale margins will exceed consolidated non-GAAP gross margins of 72.8%

    80% confidence
  • Three other institutions in discussions for D-Wave system sales

    80% confidence
  • D-Wave was first to launch commercial quantum systems, first to have quantum applications running in production, first to achieve quantum supremacy on real-world problem

    80% confidence
  • Supercomputer solution for magnetic material simulation would require more than world's annual electricity consumption

    80% confidence
  • D-Wave's cash position provides sufficient capital to get D-Wave to profitability faster than any other independent quantum company and with far less total investment

    80% confidence

Data points we hold from this source

D-Wave Quantum Inc. · average share price atm4.30 USD_per_share
D-Wave Quantum Inc. · warrant liability charge68.3 million_USD
D-Wave Quantum Inc. · customer count total133 customers
D-Wave Quantum Inc. · customer count research government55 customers
D-Wave Quantum Inc. · eloc remaining capacity37.8 million_USD
D-Wave Quantum Inc. · vwap4.22 USD_per_share
D-Wave Quantum Inc. · customer count forbes global 200028 customers
D-Wave Quantum Inc. · customer count commercial76 customers
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
D-Wave (QBTS) Q4 2024 Earnings Call Transcript — Source | Via News | es.VIA.NEWS